Results 1 to 10 of about 33,749 (144)
Matrix metalloproteinase‐9: A magic drug target in neuropsychiatry? [PDF]
Journal of Neurochemistry, 2023 Neuropsychiatric conditions represent a major medical and societal challenge. The etiology of these conditions is very complex and combines genetic and environmental factors. The latter, for example, excessive maternal or early postnatal inflammation, as
Krzysztof T Kaczmarek +2 more
semanticscholar +2 more sources
Neuroimaging-Based Brain Age Estimation: A Promising Personalized Biomarker in Neuropsychiatry [PDF]
Journal of Personalized Medicine, 2022 It is now possible to estimate an individual’s brain age via brain scans and machine-learning models. This validated technique has opened up new avenues for addressing clinical questions in neurology, and, in this review, we summarize the many clinical ...
Daichi Sone, I. Beheshti
semanticscholar +2 more sources
Editorial of Special Issue “Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry” [PDF]
Biomedicines, 2021 "Where there is light, there must be shadow, [...].
Masaru Tanaka, L. Vécsei
semanticscholar +2 more sources
Brain age and other bodily ‘ages’: implications for neuropsychiatry [PDF]
Molecular Psychiatry, 2018 As our brains age, we tend to experience cognitive decline and are at greater risk of neurodegenerative disease and dementia. Symptoms of chronic neuropsychiatric diseases are also exacerbated during ageing.
J. Cole, R. Marioni, S. Harris, I. Deary
semanticscholar +2 more sources
Training in neuropsychiatry: views of early career psychiatrists from across the world
BJPsych Bulletin, 2023 Background Training and practice in neuropsychiatry varies across the world. However, little is known about the experiences and opinions of early career psychiatrists (ECPs) across different countries regarding neuropsychiatry.
R. Molina-Ruiz +18 more
semanticscholar +1 more source
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy
CNS Spectrums, 2022 Psilocybin is a tryptamine alkaloid found in some mushrooms, especially those of the genus Psilocybe. Psilocybin has four metabolites including the pharmacologically active primary metabolite psilocin, which readily enters the systemic circulation.
S. Dodd +6 more
semanticscholar +1 more source
Biomedicines, 2022 "To learning much inclined, who went to see the Elephant (though all of them were blind) that each by observation might satisfy the mind" [...].
Masaru Tanaka +2 more
semanticscholar +1 more source
Molecular Psychiatry, 2022 Depressive disorders are the most burdensome psychiatric disorders worldwide. Although huge efforts have been made to advance treatment, outcomes remain unsatisfactory.
I. von Mücke-Heim +5 more
semanticscholar +1 more source
Journal of Neurology Neurosurgery & Psychiatry, 2021 There is accumulating evidence of the neurological and neuropsychiatric features of infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the characteristics of the early literature and estimate point prevalences ...
Jonathan P. Rogers +29 more
semanticscholar +1 more source
An Overview of Deep Learning Algorithms and Their Applications in Neuropsychiatry
Clinical Psychopharmacology and Neuroscience, 2021 Deep learning (DL) algorithms have achieved important successes in data analysis tasks, thanks to their capability of revealing complex patterns in data.
Gokhan Guney +6 more
semanticscholar +1 more source